Key Market Indicators
Canadian Hypnotic and Sedative Medicine Sales are projected to reach $125 million by 2026. Currently, the market is valued at $142 million and is expected to fall by an average of 1.6% annually over the next five years. Since 2017, Canada has seen a steady decrease of 1.6% year on year. Germany, Sweden and Belgium rank second, third and fourth respectively in this market.